145 related articles for article (PubMed ID: 33741177)
1. Development and validation of the Brigham Eyelash Tool for Alopecia (BELA): A measure of eyelash alopecia areata.
Manjaly P; Li SJ; Tkachenko E; Ko JM; Liu KJ; Scott DA; Senna MM; Joyce CJ; Mostaghimi A; Huang KP
J Am Acad Dermatol; 2021 Jul; 85(1):271-272. PubMed ID: 33741177
[No Abstract] [Full Text] [Related]
2. Eyelash alopecia areata: case series and literature review.
Modjtahedi BS; Kishan AU; Schwab IR; Jackson WB; Maibach HI
Can J Ophthalmol; 2012 Aug; 47(4):333-8. PubMed ID: 22883840
[TBL] [Abstract][Full Text] [Related]
3. Alopecia areata of the eyelashes.
Koblenzer PJ
Cutis; 2002 Sep; 70(3):161; author reply 161. PubMed ID: 12353889
[No Abstract] [Full Text] [Related]
4. Topical bimatoprost in the treatment of eyelash loss in alopecia totalis and universalis: A prospective, open-label study.
Ricar J; Cetkovska P; Hordinsky M; Ricarova R
Dermatol Ther; 2022 Jun; 35(6):e15438. PubMed ID: 35278027
[TBL] [Abstract][Full Text] [Related]
5. Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata.
Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes FP; Dutronc Y; Mesinkovska N; Ko JM; King BA
Am J Clin Dermatol; 2020 Oct; 21(5):725-732. PubMed ID: 32803546
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows.
Faghihi G; Andalib F; Asilian A
Eur J Dermatol; 2009; 19(6):586-7. PubMed ID: 19620039
[TBL] [Abstract][Full Text] [Related]
7. [Madarosis and alopecia areata of eyelashes].
Offret H; Venencie PY; Gregoire-Cassoux N
J Fr Ophtalmol; 1994; 17(8-9):486-8. PubMed ID: 7989654
[TBL] [Abstract][Full Text] [Related]
8. Acquired eyelash trichomegaly and alopecia areata in a human immunodeficiency virus-infected patient.
Grossman MC; Cohen PR; Grossman ME
Dermatology; 1996; 193(1):52-3. PubMed ID: 8864621
[TBL] [Abstract][Full Text] [Related]
9. Alopecia areata severity index (AASI): A reliable scoring system to assess the severity of alopecia areata on face and scalp-a pilot study.
Majid I; Sameem F; Sultan J; Aleem S
J Cosmet Dermatol; 2021 Aug; 20(8):2565-2570. PubMed ID: 34129730
[TBL] [Abstract][Full Text] [Related]
10. Brigham Eyebrow Tool for Alopecia: A Reliable Assessment of Eyebrow Alopecia Areata.
Tkachenko E; Huang KP; Ko JM; Liu KJ; Scott DA; Senna MM; Li SJ; Joyce CJ; Mostaghimi A
J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S41-S44. PubMed ID: 33099383
[TBL] [Abstract][Full Text] [Related]
11. What is your Diagnosis? Alopecia areata of the eyelashes.
Elston DM
Cutis; 2002 Jan; 69(1):15, 19-20. PubMed ID: 11829171
[No Abstract] [Full Text] [Related]
12. An exceptional case with unilateral eyelash loss due to intracranial lesion.
Soyer E; Orenay OM; Aksakal AB
J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):e174-e175. PubMed ID: 27726199
[No Abstract] [Full Text] [Related]
13. Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis.
Coronel-Pérez IM; Rodríguez-Rey EM; Camacho-Martínez FM
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):481-5. PubMed ID: 20028444
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial impact of pediatric alopecia areata: A survey study.
Benton S; Bellefeuille G; Rypka K; Nguyen A; Raymond O; Gorbatenko-Roth K; Maguiness S; Hordinsky MK
Pediatr Dermatol; 2023 Mar; 40(2):312-314. PubMed ID: 36722625
[TBL] [Abstract][Full Text] [Related]
15. Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata.
Ochoa BE; Sah D; Wang G; Stamper R; Price VH
J Am Acad Dermatol; 2009 Sep; 61(3):530-2. PubMed ID: 19700021
[No Abstract] [Full Text] [Related]
16. Cyclosporine for moderate-to-severe alopecia areata: A double-blind, randomized, placebo-controlled clinical trial of efficacy and safety.
Lai VWY; Chen G; Gin D; Sinclair R
J Am Acad Dermatol; 2019 Sep; 81(3):694-701. PubMed ID: 31048013
[TBL] [Abstract][Full Text] [Related]
17. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata.
Roseborough I; Lee H; Chwalek J; Stamper RL; Price VH
J Am Acad Dermatol; 2009 Apr; 60(4):705-6. PubMed ID: 19293023
[No Abstract] [Full Text] [Related]
18. Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia.
Barrón-Hernández YL; Tosti A
Expert Opin Investig Drugs; 2017 Apr; 26(4):515-522. PubMed ID: 28264599
[TBL] [Abstract][Full Text] [Related]
19. Pediatric severity of alopecia tool.
Bernardis E; Nukpezah J; Li P; Christensen T; Castelo-Soccio L
Pediatr Dermatol; 2018 Jan; 35(1):e68-e69. PubMed ID: 29105836
[TBL] [Abstract][Full Text] [Related]
20. Alopecia areata of eyelashes: a subset of alopecia areata.
Grandhe NP; Kanwar AJ
Dermatol Online J; 2004 Oct; 10(2):13. PubMed ID: 15530303
[No Abstract] [Full Text] [Related]
[Next] [New Search]
